Wipro Consumer Care acquires 60% of Dermatouch in ₹387.5 crore skincare deal

Wipro Consumer Care & Lighting has acquired a 60% stake in Ahmedabad-based D2C skincare brand Dermatouch at an enterprise value of ₹387.5 crore. The company plans to buy the remaining stake over three years, pairing Dermatouch’s digital traction with Wipro’s distribution, R&D and international reach.

— Source published Wed, 19 Aug, 2026, 17:33 IST · First seen Wed, 19 Aug, 2026, 17:36 IST · Source IndianWeb2

What happened

Wipro Consumer Care & Lighting acquired 60% of Ahmedabad skincare D2C brand Dermatouch for ₹387.5 crore, entering India’s premium digital-first skincare

Key facts

  • 60% stake acquired
  • ₹387.5 crore enterprise value
  • remaining 40% stake to be acquired over three years
  • Dermatouch FY26 revenue: ₹131 crore
  • FY26 revenue growth: 114% YoY
  • sales grew from about 60,000 products/month two years ago to more than 60,000 products/day in 2026

Why this matters

This controlling acquisition gives Wipro an immediate premium skincare platform and a phased path to full ownership, illustrating how established consumer groups can use D2C deals to enter high-growth beauty segments.

What to watch

  • Dermatouch revenue growth, repeat-purchase rates and EBITDA trajectory after integration.
  • Expansion into offline retail, pharmacy chains and beauty specialty stores, including store count and sales productivity.
  • Changes in paid-marketing intensity, customer-acquisition cost and marketplace dependence.
  • New product launches in acne, pigmentation, barrier repair, sunscreen and hair/skin treatment segments.
  • Founder retention, management changes and the terms or valuation used for Wipro's purchase of the remaining 40%.
  • Competitive responses from HUL, Nykaa, L'Oréal, Honasa, Beiersdorf and consumer-health companies in dermocosmetic skincare.
  • Launch Dermatouch selectively in Wipro's pharmacy, modern-trade and premium beauty distribution network rather than mass rollout.
  • Increase investment in clinical claims, dermatologist advocacy, ingredient-led product extensions and regulatory-quality testing.
  • Use Wipro's R&D and sourcing capabilities to improve margins, develop localized formulations and reduce dependence on paid digital customer acquisition.
  • Establish retention incentives and operating autonomy for Dermatouch's founders and digital-growth team ahead of the phased acquisition of the remaining stake.
  • Test international expansion in Wipro's existing South Asian, Middle Eastern and African consumer-markets footprint.